NCT01958853View on ClinicalTrials.gov

Prospective Evaluation of Reduced Impedance Noninvasive Cortical Electrostimulation (RINCE) to Reduce Fibromyalgia Effects - Extension Study

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Fibromyalgia
Interventions
DEVICE

RINCE

The NeuroPoint device is used to deliver repeat applications of RINCE therapy

Trial Locations (1)

48341

St. Joseph Mercy Oakland, Pontiac

Sponsors
All Listed Sponsors
lead

Cerephex Corporation

INDUSTRY

NCT01958853 - Prospective Evaluation of Reduced Impedance Noninvasive Cortical Electrostimulation (RINCE) to Reduce Fibromyalgia Effects - Extension Study | Biotech Hunter | Biotech Hunter